title: Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
abstract: Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.
authors.affiliation: Department of Pharmacological Sciences, University of Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Zuccato
authors.forename: A
authors.initials: A
authors.lastname: Ciammola
authors.forename: D
authors.initials: D
authors.lastname: Rigamonti
authors.forename: B R
authors.initials: BR
authors.lastname: Leavitt
authors.forename: D
authors.initials: D
authors.lastname: Goffredo
authors.forename: L
authors.initials: L
authors.lastname: Conti
authors.forename: M E
authors.initials: ME
authors.lastname: MacDonald
authors.forename: R M
authors.initials: RM
authors.lastname: Friedlander
authors.forename: V
authors.initials: V
authors.lastname: Silani
authors.forename: M R
authors.initials: MR
authors.lastname: Hayden
authors.forename: T
authors.initials: T
authors.lastname: Timmusk
authors.forename: S
authors.initials: S
authors.lastname: Sipione
authors.forename: E
authors.initials: E
authors.lastname: Cattaneo
mesh_terms: D016475:3T3 Cells; D000818:Animals; D017209:Apoptosis; D019208:Brain-Derived Neurotrophic Factor / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism; D002470:Cell Survival; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000378:metabolism*; D003342:Corpus Striatum / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D005091:Exons; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D009410:Nerve Degeneration; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000502:physiology*; D009474:Neurons / Q000378:metabolism* / Q000473:pathology; D009687:Nuclear Proteins / Q000235:genetics / Q000502:physiology*; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D014162:Transfection
chemical_list: D019208:Brain-Derived Neurotrophic Factor; C086055:HTT protein, human; C506812:Htt protein, mouse; D000071058:Huntingtin Protein; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins